However, more recently it has been shown that the expression of HLA-G by circulating blasts from AML, CML, but not B-ALL, and by B-CLL cells was strongly associated with an unfavorable outcome of the disease [22–24]. This evidence concerns the gene HLA-G and chronic myelogenous leukemia, BCR-ABL1 positive.